|
GB1293565A
(en)
|
1969-05-03 |
1972-10-18 |
Aspro Nicholas Ltd |
Aminophthalazines and pharmaceutical compositions thereof
|
|
GB1303061A
(enExample)
*
|
1969-05-03 |
1973-01-17 |
|
|
|
GB2063249A
(en)
*
|
1979-10-09 |
1981-06-03 |
Mitsubishi Yuka Pharma |
4-Phenylphthalazine derivatives
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
AU3752589A
(en)
|
1988-05-16 |
1989-12-12 |
Georgia State University Research Foundation, Inc. |
Nucleic acid interacting unfused heteropolycyclic compounds
|
|
JPH03284669A
(ja)
*
|
1990-03-30 |
1991-12-16 |
Mitsubishi Kasei Corp |
４―フェニルフタラジン誘導体
|
|
DE69105572T2
(de)
|
1990-03-30 |
1995-05-11 |
Mitsubishi Chem Ind |
4-Phenylphthalazin-Derivate.
|
|
TW279162B
(enExample)
*
|
1991-09-26 |
1996-06-21 |
Mitsubishi Chem Corp |
|
|
ES2125325T3
(es)
|
1992-01-23 |
1999-03-01 |
Pfizer |
Derivados de 4-fenil-3-(heteroarilureido)-1,2-dihidro-2-oxoquinolina como agentes antihipercolesterolemicos y antiateroscleroticos.
|
|
US5565472A
(en)
|
1992-12-21 |
1996-10-15 |
Pfizer Inc. |
4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
|
|
DE4417746A1
(de)
|
1994-05-20 |
1995-11-23 |
Bayer Ag |
Neue Farbstoffe zum Massefärben von Kunststoffen
|
|
DE69533057T2
(de)
|
1994-08-09 |
2005-06-16 |
Eisai Co., Ltd. |
Kondensierte pyridazinverbindungen
|
|
US5763263A
(en)
|
1995-11-27 |
1998-06-09 |
Dehlinger; Peter J. |
Method and apparatus for producing position addressable combinatorial libraries
|
|
CN1121220C
(zh)
|
1996-08-20 |
2003-09-17 |
卫材株式会社 |
稠合哒嗪系化合物的勃起机能不全症治疗剂
|
|
US20030124053A1
(en)
|
1996-10-07 |
2003-07-03 |
Barrett John Andrew |
Radiopharmaceuticals for imaging infection and inflammation
|
|
ATE236134T1
(de)
|
1996-12-18 |
2003-04-15 |
Neurogen Corp |
Isoquinolinamin und phtalazinamin derivate, die reagieren mit crf rezeptoren
|
|
US6486158B1
(en)
|
1998-08-14 |
2002-11-26 |
Cell Pathways, Inc. |
[4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasia
|
|
AU765128B2
(en)
|
1999-03-22 |
2003-09-11 |
Bristol-Myers Squibb Company |
Fused pyridopyridazine inhibitors of cGMP phosphodiesterase
|
|
CN1596263A
(zh)
|
2001-11-30 |
2005-03-16 |
辉瑞产品公司 |
芳基－稠合的氮杂多环化合物
|
|
US20040242886A1
(en)
|
2003-04-30 |
2004-12-02 |
Sandeep Gupta |
Monocyclic diazodioxide based Bcl-2 protein antagonists related applications
|
|
WO2005016000A1
(en)
|
2003-08-05 |
2005-02-24 |
Avalon Pharmaceuticals |
Derivatives of cyclic quinone and uses thereof
|
|
US7087621B2
(en)
|
2003-09-05 |
2006-08-08 |
Bristol-Myers Squibb Company |
Benzo- and azabenzodithiazole compounds
|
|
WO2005033288A2
(en)
|
2003-09-29 |
2005-04-14 |
The Johns Hopkins University |
Hedgehog pathway antagonists
|
|
WO2006004589A2
(en)
*
|
2004-05-08 |
2006-01-12 |
Neurogen Corporation |
3-aryl-5,6-disubstituted pyridazines
|
|
EP1773853A1
(en)
|
2004-06-09 |
2007-04-18 |
Sumitomo Chemical Company, Limited |
Monophosphine compounds, transition metal complexes thereof and production of optically active compounds using the complexes as asymmetric catalysts
|
|
US20060156485A1
(en)
|
2005-01-14 |
2006-07-20 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
|
WO2006090273A2
(en)
|
2005-02-22 |
2006-08-31 |
Warner-Lambert Company Llc |
[1,8]naphthyridin-2-ones and related compounds with keto or hydroxyl linkers for the treatment of schizophrenia
|
|
WO2006110516A1
(en)
|
2005-04-11 |
2006-10-19 |
Abbott Laboratories |
Acylhydrazide p2x7 antagonists and uses thereof
|
|
US8106066B2
(en)
|
2005-09-23 |
2012-01-31 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
|
|
CN101312968A
(zh)
|
2005-09-23 |
2008-11-26 |
记忆药物公司 |
吲唑、苯并噻唑、苯并异噻唑、苯并异噁唑、吡唑并吡啶、异噻唑并吡啶及其制备和用途
|
|
FR2891828B1
(fr)
|
2005-10-12 |
2007-12-21 |
Sanofi Aventis Sa |
Derives de la 1-amino-phtalazine substituee, leur preparation et leur application en therapeutique
|
|
EP1960356A2
(en)
|
2005-11-03 |
2008-08-27 |
Ilypsa, Inc. |
Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors
|
|
WO2007056184A2
(en)
|
2005-11-03 |
2007-05-18 |
Ilypsa, Inc. |
Azaindole compounds and use thereof as phospholipase-a2 inhibitors
|
|
US20070179123A1
(en)
|
2005-11-08 |
2007-08-02 |
Chiang Peter K |
Methods and compositions for treating diseases associated with pathogenic proteins
|
|
JP2009120486A
(ja)
|
2005-12-05 |
2009-06-04 |
Mitsubishi Pharma Corp |
核内オーファン受容体の新規活性化剤及びその用途
|
|
US7560551B2
(en)
|
2006-01-23 |
2009-07-14 |
Amgen Inc. |
Aurora kinase modulators and method of use
|
|
DK1984353T3
(en)
|
2006-01-23 |
2016-03-14 |
Amgen Inc |
Aurorakinasemodulatorer and method of use
|
|
US8658801B2
(en)
|
2006-02-16 |
2014-02-25 |
Syngenta Crop Protection, Llc |
Pesticides containing a bicyclic bisamide structure
|
|
CA2660114A1
(en)
|
2006-08-09 |
2008-02-14 |
Merck Frosst Canada Ltd. |
Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
CA2682676A1
(en)
|
2007-04-19 |
2008-10-30 |
Novartis Ag |
Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5
|
|
EP2155746A2
(en)
|
2007-05-04 |
2010-02-24 |
Amgen, Inc |
Diazaquinolones that inhibit prolyl hydroxylase activity
|
|
US9023490B2
(en)
|
2007-06-15 |
2015-05-05 |
Versitech Limited |
Extended pi-conjugated platinum (II) complexes
|
|
US8222251B2
(en)
|
2007-09-07 |
2012-07-17 |
Amgen Inc. |
Pyridopyridazine compounds, compositions and methods of use
|
|
WO2009038812A1
(en)
|
2007-09-20 |
2009-03-26 |
Amgen Inc. |
Condensed piperidine derivatives useful as vanilloid receptor ligands
|
|
WO2009079008A1
(en)
|
2007-12-19 |
2009-06-25 |
Yangbo Feng |
Benzopyrans and analogs as rho kinase inhibitors
|
|
WO2009086303A2
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
US8932557B2
(en)
|
2008-02-14 |
2015-01-13 |
Eli Lilly And Company |
Imaging agents for detecting neurological dysfunction
|
|
US8445473B2
(en)
|
2008-04-11 |
2013-05-21 |
The Regents Of The University Of Michigan |
Heteroaryl-substituted bicyclic Smac mimetics and the uses thereof
|
|
CA2723727A1
(en)
|
2008-05-15 |
2009-11-19 |
Merck Sharp & Dohme Corp. |
Oxazolobenzimidazole derivatives
|
|
HRP20131069T1
(hr)
|
2008-06-16 |
2013-12-20 |
Merck Patent Gmbh |
Derivati kinoksalindiona
|
|
WO2009157386A1
(ja)
|
2008-06-25 |
2009-12-30 |
住友化学株式会社 |
光学活性アミン化合物の製造方法
|
|
US20110218211A1
(en)
|
2008-08-16 |
2011-09-08 |
Genentech, Inc. |
Azaindole inhibitors of iap
|
|
EP2346334A1
(en)
|
2008-09-26 |
2011-07-27 |
Merck Sharp & Dohme Corp. |
Oxazolobenzimidazole derivatives
|
|
AU2010221417A1
(en)
|
2009-03-02 |
2011-09-22 |
Sirtris Pharmaceuticals, Inc. |
8-substituted quinolines and related analogs as sirtuin modulators
|
|
TW201040191A
(en)
|
2009-03-27 |
2010-11-16 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
|
|
EP2414353A1
(en)
|
2009-04-01 |
2012-02-08 |
Basf Se |
Isoxazoline compounds for combating invertebrate pests
|
|
US9593108B2
(en)
|
2009-04-06 |
2017-03-14 |
Ptc Therapeutics, Inc. |
Compounds and methods for antiviral treatment
|
|
WO2010117936A1
(en)
|
2009-04-06 |
2010-10-14 |
Schering Corporation |
Combinations of a hcv inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent
|
|
CN102625799A
(zh)
|
2009-06-25 |
2012-08-01 |
安姆根有限公司 |
杂环化合物及其用途
|
|
EP2459543B1
(en)
|
2009-07-29 |
2017-08-30 |
Karus Therapeutics Limited |
Benzo[e][1,3]oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors
|
|
US8846673B2
(en)
|
2009-08-11 |
2014-09-30 |
Bristol-Myers Squibb Company |
Azaindazoles as kinase inhibitors and use thereof
|
|
US20110152246A1
(en)
|
2009-12-18 |
2011-06-23 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
|
US8759535B2
(en)
|
2010-02-18 |
2014-06-24 |
High Point Pharmaceuticals, Llc |
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
|
|
UY33304A
(es)
|
2010-04-02 |
2011-10-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
|
US8980929B2
(en)
|
2010-05-21 |
2015-03-17 |
Merck Sharp & Dohme Corp. |
Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
|
|
AU2011273931B2
(en)
|
2010-06-28 |
2015-04-23 |
Merck Patent Gmbh |
2,4- diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer
|
|
MX2012015143A
(es)
|
2010-06-30 |
2013-07-03 |
Amgen Inc |
Compuestos heterociclicos que contienen nitrogeno como inhibidores de pi3k delta.
|
|
EP2616443A1
(en)
|
2010-09-14 |
2013-07-24 |
Exelixis, Inc. |
Phtalazine derivatives as jak1 inhibitors
|
|
MX336726B
(es)
|
2010-09-27 |
2016-01-27 |
Abbott Gmbh & Co Kg |
Compuestos heterociclicos y su uso como inhibidores de la glucogeno sintasa quinasa-3.
|
|
US20140107151A1
(en)
|
2011-05-17 |
2014-04-17 |
Principia Biophama Inc. |
Tyrosine kinase inhibitors
|
|
WO2012156400A1
(en)
|
2011-05-18 |
2012-11-22 |
Syngenta Participations Ag |
Insecticidal compounds based on arylthioacetamide derivatives
|
|
JP5978302B2
(ja)
|
2011-08-08 |
2016-08-24 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ |
リゾホスファチジン酸アンタゴニストとしての（ｎ−ベンズイミダゾール−２−イル）−シクロプロパンカルボキサミド
|
|
WO2013026939A1
(en)
|
2011-08-25 |
2013-02-28 |
Syngenta Participations Ag |
Methods for the control of termites and ants
|
|
WO2013078254A1
(en)
|
2011-11-22 |
2013-05-30 |
Array Biopharma Inc. |
Bicyclic heteroaryl derivatives as kinase inhibitors
|
|
UA112897C2
(uk)
|
2012-05-09 |
2016-11-10 |
Байєр Фарма Акцієнгезелльшафт |
Біциклічно заміщені урацили та їх застосування для лікування і/або профілактики захворювань
|
|
CN104781234A
(zh)
|
2012-05-22 |
2015-07-15 |
伊莱利利公司 |
用于检测神经功能障碍的基于咔啉和咔唑的成像剂
|
|
TWI610916B
(zh)
|
2012-08-03 |
2018-01-11 |
廣東東陽光藥業有限公司 |
作爲丙型肝炎抑制劑的橋環化合物及其在藥物中的應用
|
|
EP2922837A1
(en)
|
2012-11-21 |
2015-09-30 |
Syngenta Participations AG |
Insecticidal compounds based on n-(arylsulfanylmethyl) carboxamide derivatives
|
|
WO2014079935A1
(en)
|
2012-11-21 |
2014-05-30 |
Syngenta Participations Ag |
Insecticidal compounds based on arylthioacetamide derivatives
|
|
US9765039B2
(en)
|
2012-11-21 |
2017-09-19 |
Zenith Epigenetics Ltd. |
Biaryl derivatives as bromodomain inhibitors
|
|
WO2014086737A1
(de)
|
2012-12-06 |
2014-06-12 |
Bayer Cropscience Ag |
Kondensierte 2-pyridon-3-carboxamide und ihre verwendung als herbizide
|
|
TW201439060A
(zh)
|
2013-02-27 |
2014-10-16 |
Sunshine Lake Pharma Co Ltd |
作爲丙型肝炎抑制劑的橋環化合物及其藥物組合物和用途
|
|
GB201311953D0
(en)
|
2013-07-03 |
2013-08-14 |
Redx Pharma Ltd |
Compounds
|
|
AR097631A1
(es)
|
2013-09-16 |
2016-04-06 |
Bayer Pharma AG |
Trifluorometilpirimidinonas sustituidas con heterociclos y sus usos
|
|
UY35809A
(es)
|
2013-11-05 |
2015-05-29 |
Bayer Pharma AG |
(aza)piridopirazolopirimidinonas e indazolopirimidinonas y sus usos
|
|
DK3126330T3
(en)
|
2014-04-04 |
2019-04-23 |
Pfizer |
BICYCLE-FUSED HETEROARYL OR ARYL COMPOUNDS AND USE THEREOF AS IRAC4 INHIBITORS
|
|
CN103992311B
(zh)
|
2014-06-20 |
2017-01-25 |
东南大学 |
Hedgehog信号通路抑制剂
|
|
US9617279B1
(en)
|
2014-06-24 |
2017-04-11 |
Bristol-Myers Squibb Company |
Imidazooxadiazole compounds
|
|
EP3632915A1
(en)
|
2014-11-27 |
2020-04-08 |
Genentech, Inc. |
4,5,6,7-tetrahydro-1 h-pyrazolo[4,3-c]pyridin-3-amine compounds as cbp and/or ep300 inhibitors
|
|
WO2016103037A1
(en)
|
2014-12-22 |
2016-06-30 |
Akarna Therapeutics, Ltd. |
Fused bicyclic compounds for the treatment of disease
|
|
US20180093956A1
(en)
|
2015-02-06 |
2018-04-05 |
Abbvie Inc. |
Substituted phthalazines
|
|
KR102727059B1
(ko)
|
2015-02-16 |
2024-11-05 |
더 유니버서티 어브 퀸슬랜드 |
설포닐우레아와 관련 화합물 및 그 용도
|
|
IL294124B2
(en)
|
2015-12-10 |
2024-02-01 |
Ptc Therapeutics Inc |
Methods for treating huntington's disease
|
|
FR3046933B1
(fr)
|
2016-01-25 |
2018-03-02 |
Galderma Research & Development |
Inhibiteurs nlrp3 pour le traitement des pathologies cutanees inflammatoires
|
|
EA201891674A1
(ru)
|
2016-02-12 |
2019-01-31 |
Фармаксис Лтд. |
Ингибиторы лизилоксидаз, представляющие собой индольные и азаиндольные производные галогеналлиламина, и их применения
|
|
CN109071454B
(zh)
|
2016-02-16 |
2023-02-17 |
昆士兰大学 |
磺酰脲和相关化合物及其用途
|
|
WO2017144341A1
(de)
|
2016-02-23 |
2017-08-31 |
Bayer Cropscience Aktiengesellschaft |
Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
|
|
EP3236267B1
(en)
|
2016-04-18 |
2021-09-08 |
Roche Diagnostics GmbH |
Decapper and apparatus
|
|
US11597706B2
(en)
|
2016-04-18 |
2023-03-07 |
Novartis Ag |
Compounds and compositions for treating conditions associated with NLRP activity
|
|
ES2940611T3
(es)
|
2016-04-18 |
2023-05-09 |
Novartis Ag |
Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad de NLRP
|
|
EP3272739A1
(en)
|
2016-07-20 |
2018-01-24 |
NodThera Limited |
Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
|
|
WO2018031680A1
(en)
|
2016-08-10 |
2018-02-15 |
Fronthera U.S. Pharmaceuticals Llc |
Novel compounds, uses and methods for their preparation
|
|
US10947241B2
(en)
*
|
2016-10-28 |
2021-03-16 |
Seoul National University Hospital |
Phenyl phthalazine derivative, method for the preparation thereof, and pharmaceutical composition comprising the same
|
|
WO2018138050A1
(de)
|
2017-01-26 |
2018-08-02 |
Bayer Aktiengesellschaft |
Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
|
|
IL312367A
(en)
|
2017-01-31 |
2024-06-01 |
Arvinas Operations Inc |
Cereblon ligands and bifunctional compounds comprising the same
|
|
WO2018172925A1
(en)
|
2017-03-23 |
2018-09-27 |
Vitas Pharma Research Pvt Ltd |
Inhibitors of dna gyrase for treatment of bacterial infections
|
|
WO2018174678A1
(ko)
|
2017-03-24 |
2018-09-27 |
희성소재(주) |
헤테로고리 화합물 및 이를 포함하는 유기 발광 소자
|
|
KR101943428B1
(ko)
|
2017-03-24 |
2019-01-30 |
엘티소재주식회사 |
유기 발광 소자 및 유기 발광 소자의 유기물층용 조성물
|
|
AU2018273356B2
(en)
|
2017-05-22 |
2021-09-16 |
Amgen Inc. |
KRAS G12C inhibitors and methods of using the same
|
|
CN110869357A
(zh)
|
2017-05-25 |
2020-03-06 |
亚瑞克西斯制药公司 |
化合物及其用于治疗癌症的使用方法
|
|
WO2018221433A1
(ja)
|
2017-05-29 |
2018-12-06 |
第一三共株式会社 |
ヘテロアリールアミン誘導体
|
|
JP6849248B2
(ja)
|
2017-07-20 |
2021-03-24 |
エルジー・ケム・リミテッド |
化合物およびこれを含む有機発光素子
|
|
MX2020001776A
(es)
|
2017-08-15 |
2020-03-24 |
Inflazome Ltd |
Sulfonilureas y sulfoniltioureas como inhibidores de nlrp3.
|
|
TWI791593B
(zh)
|
2017-08-21 |
2023-02-11 |
德商馬克專利公司 |
做為腺苷受體拮抗劑之苯并咪唑衍生物
|
|
CN110526898A
(zh)
|
2018-05-25 |
2019-12-03 |
北京诺诚健华医药科技有限公司 |
3-吲唑啉酮类化合物、其制备方法及其在医药学上的应用
|
|
CN110563722A
(zh)
|
2018-06-06 |
2019-12-13 |
上海青煜医药科技有限公司 |
吡啶或哒嗪并环化合物及其应用
|
|
WO2020021015A1
(en)
|
2018-07-26 |
2020-01-30 |
Esteve Pharmaceuticals, S.A. |
New imidazopyridine derivatives for treating pain and pain related conditions
|
|
US12453279B2
(en)
|
2018-08-22 |
2025-10-21 |
Universal Display Corporation |
Organic electroluminescent materials and devices
|
|
WO2020163248A1
(en)
|
2019-02-04 |
2020-08-13 |
Skyhawk Therapeutics, Inc. |
Methods and compositions for modulating splicing
|
|
KR102721075B1
(ko)
|
2019-02-15 |
2024-10-24 |
삼성전자주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
|
AR119731A1
(es)
|
2019-05-17 |
2022-01-05 |
Novartis Ag |
Inhibidores del inflamasoma nlrp3
|
|
US11618751B1
(en)
|
2022-03-25 |
2023-04-04 |
Ventus Therapeutics U.S., Inc. |
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
|
|
CN115279739B
(zh)
*
|
2020-03-27 |
2025-07-22 |
尼科治疗有限公司 |
取代哒嗪化合物
|
|
AU2021279305A1
(en)
|
2020-05-28 |
2023-02-09 |
Janssen Pharmaceutica Nv |
Compounds
|
|
BR112021023814A2
(pt)
|
2020-06-09 |
2022-12-20 |
Pardes Biosciences Inc |
Inibidores de proteases de cisteína e métodos de uso das mesmas
|
|
WO2022135567A1
(zh)
|
2020-12-25 |
2022-06-30 |
上海拓界生物医药科技有限公司 |
一类含哒嗪的化合物及其医药用途
|
|
EP4289823A4
(en)
|
2021-02-08 |
2025-02-26 |
Medshine Discovery Inc. |
SUBSTITUTED PYRIDAZINE PHENOL DERIVATIVES
|
|
US11319319B1
(en)
|
2021-04-07 |
2022-05-03 |
Ventus Therapeutics U.S., Inc. |
Compounds for inhibiting NLRP3 and uses thereof
|
|
CA3214040A1
(en)
|
2021-04-07 |
2022-10-13 |
Forma Therapeutics, Inc. |
Inhibiting ubiquitin-specific protease 1 (usp1)
|
|
CA3218212A1
(en)
|
2021-04-28 |
2022-11-03 |
Astellas Pharma Inc. |
Substituted triazine compound
|
|
WO2022229315A1
(en)
|
2021-04-29 |
2022-11-03 |
Janssen Pharmaceutica Nv |
Phthalazinone derivatives as nlrp3 inflammasome inhibitors
|
|
AR125818A1
(es)
|
2021-05-12 |
2023-08-16 |
Hoffmann La Roche |
Inhibidores de nlrp3
|
|
TW202313577A
(zh)
|
2021-06-04 |
2023-04-01 |
瑞士商赫孚孟拉羅股份公司 |
新穎化合物
|
|
CN115433163A
(zh)
|
2021-06-05 |
2022-12-06 |
药捷安康(南京)科技股份有限公司 |
Nlrp3炎症小体抑制剂及其应用
|
|
EP4362946A4
(en)
|
2021-06-29 |
2025-05-21 |
Zomagen Biosciences Ltd |
Nlrp3 modulators
|
|
LT4363406T
(lt)
|
2021-07-02 |
2025-12-29 |
Astrazeneca Ab |
Nlrp3 inflamasomų inhibitoriai
|
|
AU2022306289A1
(en)
|
2021-07-09 |
2024-01-18 |
Aligos Therapeutics, Inc. |
Anti-viral compounds
|
|
TW202319055A
(zh)
|
2021-07-21 |
2023-05-16 |
日商安斯泰來製藥股份有限公司 |
縮環噠嗪（ｐｙｒｉｄａｚｉｎｅ）化合物
|
|
WO2023028536A1
(en)
|
2021-08-25 |
2023-03-02 |
Ptc Therapeutics, Inc. |
1,2,4-triazine derivatives useful as inhibitors of nlrp3
|
|
CN117858871A
(zh)
|
2021-08-25 |
2024-04-09 |
兹杜斯生命科学有限公司 |
用于神经炎性病症的治疗
|
|
CR20240093A
(es)
|
2021-08-25 |
2024-05-23 |
Ptc Therapeutics Inc |
Inhibidores de NLRP3
|
|
WO2023051761A1
(zh)
|
2021-09-30 |
2023-04-06 |
成都奥睿药业有限公司 |
一类取代杂芳酞嗪衍生物的药学用途及其制备方法
|
|
CA3228369A1
(en)
|
2021-10-19 |
2023-04-27 |
F. Hoffman-La Roche Ag |
Fused bicyclic heteroaryl compounds useful as nlrp3 inhibitors
|
|
WO2023066377A1
(zh)
|
2021-10-22 |
2023-04-27 |
索智生物科技（浙江）有限公司 |
一种含氮化合物、其制备方法及应用
|
|
WO2023088856A1
(en)
|
2021-11-17 |
2023-05-25 |
F. Hoffmann-La Roche Ag |
Heterocyclic nlrp3 inhibitors
|
|
WO2023088987A1
(en)
|
2021-11-19 |
2023-05-25 |
F. Hoffmann-La Roche Ag |
Pyridazine derivatives as inhibitors of nlrp3
|
|
US20250074888A1
(en)
|
2021-12-29 |
2025-03-06 |
Neumora Therapeutics, Inc. |
Pyridazine derivatives as modulators of nlrp3 inflammasome and related methods
|
|
IL314025A
(en)
|
2022-01-07 |
2024-08-01 |
Transthera Sciences Nanjing Inc |
Nlrp3 inflammasome inhibitor and uses thereof
|
|
CN116726020A
(zh)
|
2022-03-08 |
2023-09-12 |
上海拓界生物医药科技有限公司 |
一类含哒嗪的化合物的药物组合物及其医药用途
|
|
WO2023178099A1
(en)
|
2022-03-15 |
2023-09-21 |
Zomagen Biosciences Ltd |
Nlrp3 modulators
|
|
CA3246681A1
(en)
|
2022-03-25 |
2023-09-28 |
Ventus Therapeutics U.S., Inc. |
PYRIDO-[3,4-D]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 DERIVATIVES
|
|
JP2025511199A
(ja)
|
2022-03-31 |
2025-04-15 |
ハンチョウ ハイライトゥル ファーマシューティカル カンパニー リミテッド |
Ｎｌｒｐ３インフラマソーム阻害剤
|
|
AR129012A1
(es)
|
2022-04-07 |
2024-07-03 |
Takeda Pharmaceuticals Co |
Derivados de piridazina fusionados
|
|
CN116969920A
(zh)
|
2022-04-29 |
2023-10-31 |
上海辉启生物医药科技有限公司 |
稠合哒嗪衍生物及其制备方法与医药用途
|
|
JP2025517702A
(ja)
|
2022-05-13 |
2025-06-10 |
ニューモラ セラピューティクス インコーポレイテッド |
Ｎｌｒｐ３インフラマソームのモジュレーターならびに関連製品および方法
|
|
EP4531858A1
(en)
|
2022-06-03 |
2025-04-09 |
F. Hoffmann-La Roche AG |
Novel compounds
|
|
US20260015357A1
(en)
|
2022-07-01 |
2026-01-15 |
Neumora Therapeutics, Inc. |
Modulators of nlrp3 inflammasome and related products and methods
|
|
JP2025524640A
(ja)
|
2022-07-14 |
2025-07-30 |
エーシー・イミューン・エス・アー |
Ｎｌｒｐ３インフラマソーム経路の調節剤としてのピロロトリアジン及びイミダゾトリアジン誘導体
|
|
WO2024012551A1
(zh)
|
2022-07-14 |
2024-01-18 |
南京明德新药研发有限公司 |
氘取代的哒嗪苯并噻吩化合物及其应用
|
|
EP4558499A1
(en)
|
2022-07-21 |
2025-05-28 |
F. Hoffmann-La Roche AG |
Nlrp3 inhibitors
|
|
CA3261365A1
(en)
|
2022-07-28 |
2024-02-01 |
Ac Immune Sa |
NEW COMPOUNDS
|
|
UY40374A
(es)
|
2022-08-03 |
2024-02-15 |
Novartis Ag |
Inhibidores de inflamasoma nlrp3
|
|
JP2025526692A
(ja)
|
2022-08-10 |
2025-08-15 |
武田薬品工業株式会社 |
複素環式化合物
|
|
CN116789674B
(zh)
|
2022-08-24 |
2024-05-24 |
杭州高光制药有限公司 |
Nlrp3炎性小体抑制剂
|
|
IL319619A
(en)
|
2022-09-23 |
2025-05-01 |
Merck Sharp & Dohme Llc |
Phthalazine derivatives used as NOD-LIKE PROTEIN 3 receptor inhibitors
|
|
JPWO2024090469A1
(enExample)
|
2022-10-26 |
2024-05-02 |
|
|
|
US12331048B2
(en)
|
2022-10-31 |
2025-06-17 |
Ventus Therapeutics U.S., Inc. |
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
|
|
EP4612150A1
(en)
|
2022-10-31 |
2025-09-10 |
Ventus Therapeutics U.S., Inc. |
Bridged bicyclic heterocycloalkyl pyrido-[3,4-d]pyridazine amine derivatives useful as nlrp3 inhibitors
|
|
EP4611743A1
(en)
|
2022-11-02 |
2025-09-10 |
Merck Sharp & Dohme LLC |
Triazines useful as inhibitors of nod-like receptor protein 3
|
|
WO2024094150A1
(en)
|
2022-11-04 |
2024-05-10 |
Insilico Medicine Ip Limited |
Nlrp3 inflammasome inhibitors and uses thereof
|
|
AU2023371859A1
(en)
|
2022-11-04 |
2025-06-12 |
Transthera Sciences (Nanjing) , Inc. |
Nlrp3 inflammasome inhibitor and use thereof
|
|
CA3268380A1
(en)
|
2022-11-09 |
2024-05-16 |
F. Hoffmann-La Roche Ag |
TRIAZINONE DERIVATIVES USED AS NLRP3 INHIBITORS
|
|
JP2025537237A
(ja)
|
2022-11-09 |
2025-11-14 |
エフ． ホフマン－ラ ロシュ アーゲー |
Ｎｌｒｐ３阻害剤としてのトリアジノン誘導体
|
|
EP4615830A1
(en)
|
2022-11-09 |
2025-09-17 |
F. Hoffmann-La Roche AG |
Triazinone derivatives as nlrp3 inhibitors
|
|
CN118056822A
(zh)
|
2022-11-18 |
2024-05-21 |
正大天晴药业集团股份有限公司 |
一种哒嗪并环化合物及其用途
|
|
WO2024109922A1
(zh)
|
2022-11-25 |
2024-05-30 |
成都赜灵生物医药科技有限公司 |
桥环并哒嗪类化合物及其用途
|
|
PE20251845A1
(es)
|
2022-12-07 |
2025-07-17 |
Hoffmann La Roche |
Compuestos novedosos como moduladores de la inhibicion de nlrp3
|
|
EP4630420A1
(en)
|
2022-12-08 |
2025-10-15 |
F. Hoffmann-La Roche AG |
Inhibitors of nlrp3
|
|
EP4637746A1
(en)
|
2022-12-19 |
2025-10-29 |
Merck Sharp & Dohme LLC |
6,6 bicyclic heterocyles useful as inhibitors of nod-like receptor protein 3
|
|
KR20250137593A
(ko)
|
2022-12-23 |
2025-09-18 |
뉴모라 테라퓨틱스, 인코포레이티드 |
Nlrp3 인플라마솜의 조정제 및 관련 생성물 및 방법
|
|
CN120379995A
(zh)
|
2022-12-27 |
2025-07-25 |
正大天晴药业集团股份有限公司 |
一种哒嗪稠芳环化合物及其用途
|
|
TW202440107A
(zh)
|
2022-12-28 |
2024-10-16 |
瑞典商阿斯特捷利康公司 |
Ｎｌｒｐ３炎症小體抑制劑
|
|
KR20250106322A
(ko)
|
2022-12-28 |
2025-07-09 |
장춘 진사이언스 파마슈티컬 씨오., 엘티디. |
피리다진계 nlrp3 억제제 화합물, 약학 조성물 및 이의 제조 방법과 용도
|
|
EP4642784A1
(en)
|
2022-12-30 |
2025-11-05 |
PTC Therapeutics, Inc. |
Heterocyclic and heteroaryl compounds as inhibitors of nlrp3
|
|
JP2026504821A
(ja)
|
2023-01-03 |
2026-02-10 |
コディアック サイエンシーズ インコーポレイテッド |
Ｎｌｒｐ３阻害剤としての有機化合物
|
|
AU2024215094A1
(en)
|
2023-01-31 |
2025-09-11 |
Janssen Pharmaceutica Nv |
Pyridin-2(1h)-ones and pyrimidin-4(3h)-ones as nlrp3 inhibitors
|
|
KR20250151413A
(ko)
|
2023-01-31 |
2025-10-21 |
얀센 파마슈티카 엔브이 |
NLRP3 억제제로서의 이미다조[1,2-d][1,2,4]트라이아진
|
|
WO2024160694A1
(en)
|
2023-01-31 |
2024-08-08 |
Janssen Pharmaceutica Nv |
[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AND [1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS NLRP3 INHIBITORS
|
|
JP2026504419A
(ja)
|
2023-01-31 |
2026-02-05 |
ヤンセン ファーマシューティカ エヌ．ベー． |
Ｎｌｒｐ３阻害剤としての２－（ピリダジン－３－イル）－５－（トリフルオロメチル）フェノール
|
|
KR20250134147A
(ko)
|
2023-01-31 |
2025-09-09 |
얀센 파마슈티카 엔브이 |
NLRP3 억제제로서의 피롤로[1,2-d][1,2,4]트리아진 및 피라졸로[1,5-d] [1,2,4]트리아진
|